SAMRAT PHARMACHEM
Back to Cashflow Statement
|
SAMRAT PHARMACHEM Last 5 Year Cash Flow from Financing Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹0.48 Cr | ₹-11 Cr | ₹9.60 Cr | ₹-1.95 Cr | ₹-1.89 Cr |
What is the latest Cash Flow from Financing Activities ratio of SAMRAT PHARMACHEM ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹0.48 Cr |
| Mar2024 | ₹-11 Cr |
| Mar2023 | ₹9.60 Cr |
| Mar2022 | ₹-1.95 Cr |
| Mar2021 | ₹-1.89 Cr |
How is Cash Flow from Financing Activities of SAMRAT PHARMACHEM Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹0.48 Cr | Positive | |
| Mar2024 | ₹-11 Cr | Negative | |
| Mar2023 | ₹9.60 Cr | Positive | |
| Mar2022 | ₹-1.95 Cr | Negative | |
| Mar2021 | ₹-1.89 Cr | - | |
Compare Cash Flow from Financing Activities of peers of SAMRAT PHARMACHEM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SAMRAT PHARMACHEM | ₹62.6 Cr | -1.9% | -1% | -44.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹420,531.0 Cr | 1.3% | 8.9% | 6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,989.0 Cr | 2.4% | 6% | 12.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹147,936.0 Cr | -0.6% | 9.4% | 44.1% | Stock Analytics | |
| CIPLA | ₹109,200.0 Cr | 1.9% | 2% | -8.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,057.0 Cr | -0.4% | 9.5% | 10.5% | Stock Analytics | |
SAMRAT PHARMACHEM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SAMRAT PHARMACHEM | -1.9% |
-1% |
-44.9% |
| SENSEX | -3.7% |
-2.5% |
6.5% |
You may also like the below Video Courses